Assetmark, Inc Viatris Inc Transaction History

Assetmark, Inc

$32.1 Billion
Q2 2024

A detailed history of Assetmark, Inc transactions in Viatris Inc stock. As of the latest transaction made, Assetmark, Inc holds 160 shares of VTRS stock, worth $1,848. This represents 0.0% of its overall portfolio holdings.

Number of Shares

160

Previous 131 22.14%

Holding current value

$1,848

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$10.05 - $12.02 $291 - $348	29 Added 22.14%	160 $1,000
Q1 2024 May 06, 2024	SELL	$11.27 - $13.53 $1,374 - $1,650	-122 Reduced 48.22%	131 $1,000
Q4 2023 Feb 09, 2024	BUY	$8.77 - $10.85 $1,026 - $1,269	117 Added 86.03%	253 $2,000
Q3 2023 Oct 27, 2023	BUY	$9.59 - $11.35 $326 - $385	34 Added 33.33%	136 $1,000
Q2 2023 Aug 11, 2023	SELL	$9.02 - $10.29 $460 - $524	-51 Reduced 33.33%	102 $1,000
Q1 2023 May 05, 2023	BUY	$9.2 - $12.26 $423 - $563	46 Added 42.99%	153 $1,000
Q4 2022 Feb 10, 2023	SELL	$8.72 - $11.56 $209 - $277	-24 Reduced 18.32%	107 $1,000
Q3 2022 Nov 01, 2022	SELL	$8.48 - $11.13 $695 - $912	-82 Reduced 38.5%	131 $1,000
Q2 2022 Aug 03, 2022	SELL	$9.95 - $12.27 $606 - $748	-61 Reduced 22.26%	213 $2,000
Q1 2022 May 13, 2022	SELL	$9.81 - $15.4 $147 - $231	-15 Reduced 5.19%	274 $3,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $290 - $352	24 Added 9.06%	289 $4,000
Q3 2021 Nov 12, 2021	SELL	$13.25 - $15.13 $715 - $817	-54 Reduced 16.93%	265 $4,000
Q2 2021 Aug 16, 2021	SELL	$12.97 - $16.15 $1,530 - $1,905	-118 Reduced 27.0%	319 $5,000
Q1 2021 May 14, 2021	SELL	$13.59 - $18.54 $5,082 - $6,933	-374 Reduced 46.12%	437 $6,000
Q4 2020 Feb 10, 2021	BUY	$14.3 - $18.74 $11,597 - $15,198	811 New	811 $15,000

Others Institutions Holding VTRS

# of Institutions

1,100

Shares Held

969M

Call Options Held

2.63M

Put Options Held

2.15M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $14B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account